According to analysts with QuintilesIMS, Poland’s pharmaceutical market will be worth PLN 38.5 billion (EUR 9 bn) by the end of 2017, which marks a 5.4-percent hike year on year. The growing figures are largely determined by an uptick in demand for medicine available over the counter, the authors of the report said. This sector…
The Ministry of Health in Kazakhstan is introducing changes to the existing legislation for distribution of pharmaceutical products and medical devices with the view to improve regulation of prices and ‘create a patient-oriented drug provision model. According to a new draft law, in October 2018 regulated prices will be introduced for all prescription pharmaceutical products…
The healthcare spending in Poland has been steadily on the rise over the last 3 years. In 2016, the budget of the National Health Fund (NFZ) grew by 3.8% with 4.8% increase expected in 2017. The Polish government is determined to boost the 2018 NFZ budget by PLN5.5bn which would result in a total healthcare…
Johnson & Johnson Romania’s pharma company Janssen will invest over EUR 1 million in research and development in Romania. The company has expressed its willingness to collaborate with the local authorities to find new solutions to update the list of reimbursable drugs. Janssen is interested in continuing the investments in onco-hematology on the long term.…
Armenian medicine producers work with various countries to expand the geography of medicine export, Albert Sahakyan, the deputy director of “Scientific Center of Drug And Medical Technology Expertise” told Armenpress. According to him, some shifts have already been registered. “About 10% of the drugs registered in Armenia are of Armenian production and provide 7% of…
A groundbreaking ceremony was held for the first plant for production of solid consistency drugs in Azerbaijan. The plant, which will be commissioned in late 2018, will produce cardiological, nephrological, gastroenterological, diabetic and other medicine necessary for the Azerbaijani market. The products of the plant, being built by the Indian company SunPharma, which is the…
Estonian annual drug statistics is based on wholesalers’ reports. The statistics of human medicinal products includes sales to general and hospital pharmacies and to other institutions, i.e. state and scientific institutions. Wholesalers In January 2017 there were 64 wholesalers in Estonia and six of them were specialized only on veterinary medicines. 2013 2014 2015 2016…
Romania’s minister of health, Florian Bodog, says the government is looking to change the clawback tax, which has attracted criticism from the pharma industry in the past years. The tax had been rolled out in 2009, in a bid to bring more money to the healthcare budget during the crisis period. Authorities had said that…
The medical device sector is one of the most complex and challenging business segments of the healthcare industry with close collaboration between science and engineering. The main objective of the regulatory harmonization is to improve the efficiency of national economies and their ability to adopt to change and remain competitive. Due to the Medical Device…
Kelun-Kazpharm, located in outskirt of Almaty, Kazakhstan, is a Sino-Kazakh pharmaceutical joint venture controlled by a Chinese private company. Since put into operation in July 2014, the venture has not only boosted Kazakhstan’s pharmaceutical industry, but also brought win-win prosperity to Central Asia at large. As a production plant of Sichuan-based Kelun Pharmaceutical, it has…